A Pilot Randomized Controlled Trial and Multi-Omics Analysis of Electrolysed Alkaline Water: Impacts on Gut Microbiota and Metabolic Signatures in Hyperuricemia
Nutrients · 2025
DOI: 10.3390/nu18010107 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Qisijing Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, China. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Hyperuricemia, Drinking Water, Metabolome. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Kangshi Food Technology Co., Ltd., Shanghai 201103, China, Shanghai Kangshi Food Technology Co., Ltd..
Abstract (Originalsprache)
Background/Objectives: Hyperuricemia (HUA) is the second most common metabolic disease in China (24.5% in males, 3.6% in females), which can induce multiple complications such as gout and diabetes. Existing urate-lowering drugs have significant hepatorenal toxicity, necessitating safe lifestyle interventions. Electrolyzed alkaline water (EAW) as daily drinking water has shown preliminary effectiveness, but it lacks randomized controlled evidence and mechanistic studies at the microbiome–metabolome interface.
Methods
We conducted a 12-week randomized controlled trial in 40 adults aged 18–65 years with elevated serum uric acid (SUA). Participants consumed either 1.5 L/day of EAW (pH 8.5–9.5) or purified water (pH 7.0). Clinical indicators, quality of life (SF-36), gut microbiota, and gut metabolomics were comprehensively assessed to evaluate intervention efficacy and explore potential mechanisms.
Results
After 12 weeks, the EAW group exhibited a larger reduction in serum uric acid than the control group, along with improvements in selected physical health-related quality-of-life measures. Modest differences in gut microbial composition were observed between groups. Metabolomic analyses identified group-level differences in metabolites enriched in pathways related to purine metabolism and other urate-associated metabolic processes.
Conclusions
This pilot randomized controlled trial suggests that consumption of EAW is associated with a modest reduction in serum uric acid. Exploratory multi-omics analyses indicate concurrent changes in gut microbiota and metabolic profiles. These findings support further investigation of electrolyzed alkaline water as a potential adjunctive, non-pharmacological option for hyperuricemia in larger and longer-term studies. Ethics: This trial was registered with the Chinese Clinical Trial Registry under the identifier ChiCTR2500100190. Ethical approval for the present study was granted by the Nankai University Institutional Review Board (NKUIRB2025001, 23 January 2025).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tianjin Key Laboratory of Food Science and Health, School of Medicine, Nankai University, Tianjin 300071, China.
ORCID-Profile: Jin Wang
Förderung
- Shanghai Kangshi Food Technology Co., Ltd., Shanghai 201103, China
- Shanghai Kangshi Food Technology Co., Ltd.
Zitieren
APA
Liu, Q., Gu, W., Ma, J., Wang, J., Yu, M., Xu, M., & Wang, S. (2025). A Pilot Randomized Controlled Trial and Multi-Omics Analysis of Electrolysed Alkaline Water: Impacts on Gut Microbiota and Metabolic Signatures in Hyperuricemia. Nutrients. https://doi.org/10.3390/nu18010107
Vancouver
Liu Q, Gu W, Ma J, Wang J, Yu M, Xu M, et al. A Pilot Randomized Controlled Trial and Multi-Omics Analysis of Electrolysed Alkaline Water: Impacts on Gut Microbiota and Metabolic Signatures in Hyperuricemia. Nutrients. 2025. doi:10.3390/nu18010107
BibTeX
@article{Liu2025,
author = {Liu, Qisijing and Gu, Wentao and Ma, Juan and Wang, Jin and Yu, Miao and Xu, Min and Wang, Shuo},
title = {A Pilot Randomized Controlled Trial and Multi-Omics Analysis of Electrolysed Alkaline Water: Impacts on Gut Microbiota and Metabolic Signatures in Hyperuricemia},
journal = {Nutrients},
year = {2025},
doi = {10.3390/nu18010107}
}
EUVIMED